FKBP5 and breast carcinoma: Furthermore, downregulation of FKBP5 desensitised pancreatic and breast cancer cell lines to several different classes of chemotherapeutic agents, including not only cytidine analogues but also taxanes, ironotecan, and etoposide (Li et al, 2008; Pei et al, 2009).